Director/PDMR Shareholding

RNS Number : 3629S
Synectics PLC
08 March 2019
 

Synectics plc

(the "Company" or the "Group")

 

Award of Options under Share Plan

 

Directorate / PDMR Shareholding

 

8 March 2019

 

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that on 7 March 2019 it made awards over 65,000 Synectics plc ordinary shares of 20p (the "Shares") to certain Persons Discharging Managerial Responsibility ("PDMRs"), under its Performance Share Plan ("PSP"), as detailed below:

 

 

Name

Position

Status

PSP award (number of Shares)

Paul Webb

Chief Executive

Executive Director

25,000

Simon Beswick

Finance Director

Executive Director

20,000

David Lowe

Business Strategy Director

PDMR

20,000

 

Following these awards, their total interests in Shares comprise:

 

 Name

 Shares held

Interest in Shares in Synectics plc share schemes

Resultant total interest in Shares

% of issued share capital

Paul Webb

36,322

276,923

313,245

1.76

Simon Beswick

-

20,000

20,000

0.11

David Lowe

10,000

20,000

30,000

0.17

 

Under the PSP, selected employees are entitled to exercise an option to receive a certain number of Shares at any time after a 3 year vesting period, at no cost to themselves. The number of Shares that are awarded at the end of the 3 year period is dependent on the achievement of certain performance criteria.

 

Vesting of the PSP awards is dependent on the total return on Shares compared with the AIM All Share Total Return Index (the "Index"). If the total return on Shares out-performs the Index by 5% or more in the 3 years following the award, all of the Shares awarded will vest.  If Shares match the Index performance, then 25% of the awarded Shares will vest. Between these points the number of Shares that vest will be pro-rata. If the total return on Shares underperforms the Index, then no Shares will vest. The limit on the number of Shares over which interests may be awarded remains unchanged.

 

Any entitlement under the PSP will lapse on cessation of employment prior to the end of the 3 year vesting period, unless cessation of employment is by reason of redundancy, ill health or death.

 

Should the performance criteria be met in full or part, it is intended that the appropriate number of Shares will be satisfied from unallocated Shares already held within the Company's employee benefit trust.

 

Full details of the PSP were set out in the Company's Annual Report for the year ended 30 November 2017.

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

Tel: +44(0) 114 255 2509

 

Stockdale Securities

Tom Griffiths / Henry Willcocks

Tel: +44 (0) 20 7601 6100


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASDPESKNEFF

Companies

Synectics (SNX)
UK 100

Latest directors dealings